The use of alternative strategies for enhanced nanoparticle delivery to solid tumors

M Izci, C Maksoudian, BB Manshian… - Chemical …, 2021 - ACS Publications
Nanomaterial (NM) delivery to solid tumors has been the focus of intense research for over a
decade. Classically, scientists have tried to improve NM delivery by employing passive or …

Tumor extravasation and infiltration as barriers of nanomedicine for high efficacy: The current status and transcytosis strategy

Q Zhou, C Dong, W Fan, H Jiang, J Xiang, N Qiu… - Biomaterials, 2020 - Elsevier
Nanotechnology-based drug delivery platforms have been explored for cancer treatments
and resulted in several nanomedicines in clinical uses and many in clinical trials. However …

Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology

N Bertrand, J Wu, X Xu, N Kamaly… - Advanced drug delivery …, 2014 - Elsevier
Cancer nanotherapeutics are progressing at a steady rate; research and development in the
field has experienced an exponential growth since early 2000's. The path to the …

[HTML][HTML] Improving conventional enhanced permeability and retention (EPR) effects; what is the appropriate target?

H Kobayashi, R Watanabe, PL Choyke - Theranostics, 2014 - ncbi.nlm.nih.gov
Nano-sized therapeutic agents have several advantages over low molecular weight agents
such as a larger loading capacity, the ability to protect the payload until delivery, more …

Strategies to improve the EPR effect: A mechanistic perspective and clinical translation

M Ikeda-Imafuku, LLW Wang, D Rodrigues… - Journal of Controlled …, 2022 - Elsevier
Many efforts have been made to achieve targeted delivery of anticancer drugs to enhance
their efficacy and to reduce their adverse effects. These efforts include the development of …

Active targeting schemes for nanoparticle systems in cancer therapeutics

JD Byrne, T Betancourt, L Brannon-Peppas - Advanced drug delivery …, 2008 - Elsevier
The objective of this review is to outline current major cancer targets for nanoparticle
systems and give insight into the direction of the field. The major targeting strategies that …

Strategies to enhance drug delivery to solid tumors by harnessing the EPR effects and alternative targeting mechanisms

Y Zi, K Yang, J He, Z Wu, J Liu, W Zhang - Advanced Drug Delivery …, 2022 - Elsevier
Abstract The Enhanced Permeability and Retention (EPR) effect has been recognized as the
central paradigm in tumor-targeted delivery in the last decades. In the wake of this concept …

Nanoscale drug delivery systems for enhanced drug penetration into solid tumors: current progress and opportunities

CL Waite, CM Roth - Critical Reviews™ in Biomedical …, 2012 - dl.begellhouse.com
Poor penetration of anticancer drags into solid tumors significantly limits their efficacy. This
phenomenon has long been observed for small-molecule chemotherapeutics, and it can be …

Anticancer nanomedicine and tumor vascular permeability; Where is the missing link?

S Taurin, H Nehoff, K Greish - Journal of controlled release, 2012 - Elsevier
Anticancer nanomedicine was coined to describe anticancer delivery systems such as
polymer conjugates, liposomes, micelles, and metal nanoparticles. These anticancer …

Augmentation of the enhanced permeability and retention effect with nitric oxide–generating agents improves the therapeutic effects of nanomedicines

W Islam, J Fang, T Imamura, T Etrych, V Subr… - Molecular cancer …, 2018 - AACR
Enhanced permeability and retention (EPR) effect–based nanomedicine is a promising
strategy for successful anticancer therapy. The EPR effect is based on tumor blood flow …